Veterinary Vaccines Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. Soaring Demand for Animal-Derived Food Products
   3. Market Restraints
      1. High Costs of Vaccine Development and Production
      2. Stringent Regulatory Frameworks
   4. Market Opportunity
      1. Increasing Research and Development Activities
   5. Market Trends
      1. Adoption of Advanced Biotechnology in Vaccine Development
      2. Growing Focus on Preventive Healthcare and Disease Eradication Programs
5. MARKET SEGMENTATION
   1. By Product
      1. Attenuated Live Vaccines
      2. Conjugate Vaccines
      3. Inactivated Vaccines
      4. Subunit Vaccines
      5. Toxoid Vaccines
      6. DNA Vaccines
      7. Recombinant Vaccines
   2. By Disease
      1. Anaplasmosis
      2. Canine Parvovirus
      3. Foot & Mouth Disease
      4. New Castle Disease
      5. Distemper Disease
      6. Influenza
      7. Porcine Reproductive & Respiratory Syndrome (PRRS)
      8. Others
   3. By Distribution Channel
      1. Veterinary Clinics
      2. Veterinary Hospitals
      3. Veterinary Research Institutes
      4. Retail Pharmacies
   4. By Species
      1. Companion Animals
         1. Canine
         2. Avian
         3. Feline
      2. Livestock Animals
         1. Aquatic
         2. Bovine
         3. Porcine
         4. Ovine/Caprine
         5. Poultry
      3. Equine
   5. By Key Geographic Regions
      1. North America
         1. United States
         2. Canada
         3. Mexico
      2. Europe
         1. Germany
         2. United Kingdom
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
      3. Asia Pacific
         1. China
         2. Japan
         3. India
         4. Australia
         5. South Korea
         6. Rest of Asia Pacific
      4. Middle East and Africa
         1. GCC
         2. South Africa
         3. Rest of Middle East and Africa
      5. South America
         1. Brazil
         2. Argentina
         3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. Amgen Inc.
      2. AbbVie Inc.
      3. Astrazeneca
      4. Advaxis, Inc
      5. Allergan
      6. Boehringer Ingelheim International GmbH
      7. BioNTech SE
      8. Cardinal Health
      9. CureVac AG
      10. Celldex Therapeutics
      11. F. Hoffmann-La Roche Ltd
      12. GSK plc
      13. Genocea
      14. Gritstone Oncology
      15. Johnson & Johnson Services, Inc.
      16. Mylan N.V.
      17. Merck & Co., Inc.
      18. Moderna, Inc.
      19. Novartis AG
      20. Personalis Inc.
      21. Pfizer Inc.
      22. Sanofi
      23. Sun Pharmaceutical Industries Ltd.
      24. Teva Pharmaceutical Industries Ltd.
      25. Takeda Pharmaceutical Company Limited.

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

Q.1. What is the projected market value of the global Veterinary Vaccines market?

The global market of veterinary vaccinesis projected to reach USD 15.37 Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global Veterinary Vaccines market?

The global veterinary vaccinesmarket has an estimated annual growth rate of 6.1%.

Q.3. What are the recent trends of Veterinary Vaccines market?

Adoption of advanced biotechnology in vaccine development and growing focus on preventive healthcare and disease eradication programs are some of the major trends of the market that is projected to boost the market growth in the near future.

Q.4. Which are the top companies to hold the market share in Veterinary Vaccines?

The major companies profiled in this report include Boehringer Ingelheim GmbH, Bayer AG, Ceva SantéAnimale, Elanco Animal Health, Merck & Co., Inc., Phibro Animal Health Corporation, Virbac Group, Zoetis Inc., among others.

Q.5. Which is the largest regional market in the Veterinary Vaccines?

North America is the largest regional market for veterinary vaccines.